Publications, Books, Book Chapters, Reports and

(jumper’s knee). Cochrane Database of Systematic Reviews. 9:CD013034CD013034.

Cross AJ, Buchbinder R, Bourne A, Maher C, Mathieson S, Lin CC, O’Connor DA. (2019) Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: protocol for a qualitative evidence synthesis using the Theoretical Domains Framework. BMJ Open. 9(11): e034039.

Jessup RL, Oates MJ, Johnston RV, Buchbinder R. (2019). Shockwave therapy for plantar heel pain (plantar fasciitis) [Protocol] Cochrane Database of Systematic Reviews. 11:CD013490.

Sidhu VS, Graves SE, Buchbinder R, Naylor JM, Pratt NL, de Steiger RS, Chong BH, Ackerman IN, Adie S, Harris A, Hansen A, Cripps M, Lorimer M, Webb S, Clavisi O, Griffith EC, Anandan D, O’Donohue G, Kelly TL, Harris IA. (2019) CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study. BMJ Open. 9(11):e031657.

O’Keeffe M, Buchbinder R. (2019) Management of nonspecific low back pain: a growing issue. Pain Management Today. 6(2):46-53.

Karjalainen TV, Jain NB, Heikkinen H, Johnston RV, Page CM, Buchbinder R. (2019) Surgery for rotator cuff tears. Cochrane Database Syst Rev. 12:CD013502.

Joyce K, Staples M, Beauchamp A, Jessup R, Buchbinder R. (2019) The health literacy profile of clients attending a community rehabilitation program: A survey using the Health Literacy Questionnaire (HLQ). Rehabil Res Policy Educ. 34(1):1-10.

Major DH, Røe Y, Grotle M, Jessup R, Farmer C, Småstuen MC, Buchbinder R. (2019) Content reporting of exercise interventions in rotator cuff disease trials: Results from application of the Consensus on Exercise Reporting Template (CERT). BMJ Open Sport Ex Med. 5:e000656.

Suman A, Schaafsma FG, van Dongen JM, Elders PJM, Buchbinder R, van Tulder M, Anema JR. (2019) Effectiveness and cost-effectiveness of a multifaceted eHealth strategy to improve back pain beliefs of patients with non-specific low back pain: a cluster randomised trial. BMJ Open. 9:e030879.

Cai K, Whittle SL, Richards BL, Ramiro S, Falzon L, Buchbinder R. Marine oil supplements for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2019, Issue 12. Art. No.: CD010250.

Lähdeoja T, Karjalainen TV, Jokihaara J, Kavaja L, Salamh P, Agarwal A, Winters M, Buchbinder R, Vandvik PO, Arden C (2020). Subacromial decompression surgery for adults with shoulder pain – a systematic review with meta-analysis. Br J Sports Med. 54:665-73.

McKenzie JE, Brennan SE, Ryan RE, Thomson HJ, Johnston RV, Thomas J. (2020) Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition. Chichester (UK): John Wiley & Sons, [33–66]. © 2020 The Cochrane Collaboration. Published 2020 by John Wiley & Sons Ltd.

McKenzie JE, Brennan SE, Ryan RE, Thomson HJ, Johnston RV. (2020) Chapter 9: Summarizing study characteristics and preparing for synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition. Chichester (UK): John Wiley & Sons, [229–240]. © 2020 The Cochrane Collaboration. Published 2020 by John Wiley & Sons Ltd.

Wu A, March L, Zheng X, Huang J, Wang X, Zhao J, Blyth F, Smith E, Buchbinder R, Hoy D. (2020) Global Low Back Pain Prevalence and Years Lived With Disability From 1990 to 2017: Estimates From the Global Burden of Disease Study 2017. Ann Translational Med. 8(6):299.

Saeid S, Hoy D, March L, Buchbinder R, Ferreira M. (2020) Global, Regional, and National Burden of Neck Pain in the General Population, 19902017: Systematic Analysis of the Global Burden of Disease Study 2017. BMJ. 368:m791.

Hazlewood GS, Whittle SL, Kamso MM, Akl EA, Wells G, Tugwell P, Thomas M, Lee C, Choudhary D, Neuen DR, New-Tolley J, Powell M, Quinlivan A, Qaddoura A, Dearddon R, Maxwell LJ, Pardo JP, Buchbinder R. (2020) Disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a systematic review and network meta-analysis [Protocol]. Cochrane Database Syst Rev. 3:CD013562.

Jessup RL, Putrik P, Buchbinder R, Nezon J, Rischin K, Cyril S, Shepperd S, O’Connor DA. (2020) Identifying alternative models of healthcare service delivery to inform health system improvement: scoping review of systematic reviews. BMJ Open. 10(3):e036112.

Suman A, Armijo-Olivo S, Deshpande S, Marietta J, Miciak M, Werner EL, Straube S, Buchbinder R, Gross D. (2020) A systematic review of the effectiveness of mass media campaigns for the management of low back pain. Disab Rehabil. doi: 10.1080/09638288.2020. 1743777.

Buchbinder R, Busija L. (2020) Author reply to Clark et al. IMJ. 50(5):648-9.

Farmer CI, Bourne AM, O’Connor D, Jarvik JG, Buchbinder R. (2020) Enhancing clinician and patient understanding of radiology reports: a scoping review of international guidelines. Insights Imaging. 11(1):62.

Bråten LCH, Schistad EI, Espeland A, Kristoffersen PM, Haugen AJ, Marchand GH, Vetti N, Pripp AH, Kadar TI, Skouen JS, Grotle M, Grøvle L, Zwart JA, Brox JI, Storheim K; AIM-study group. (2020) Association of modic change types and their short tau inversion recovery signals with clinical characteristics – A cross sectional study of chronic low back pain patients in the AIM-study. BMC Musculoskelet Disord. 21(1):368.

Fletcher A, Lassere M, March L, Hill C, Carroll G, Barrett C, Buchbinder R. (2020) Oral complementary medicine use among people with inflammatory arthritis: An Australian Rheumatology Association Database analysis. International Journal of Rheumatology. (2):1-9.

Gearon E, Backholer K, Lal A, Nusselder W, Peeters A. (2020) The case for action on socioeconomic differences in overweight and obesity among Australian adults: modelling the disease burden and healthcare costs. ANZ J Public Health. 44(2):121-8.

Haas R, Bowles K, O’Brien L, Haines T. (2020) The effect of transferring weekend physical therapy services from the acute to sub-acute setting in patients following hip and knee arthroplasty: A quasiexperimental study. Physiother Theory Pract. doi:10.1080/09593 985.2020.1777604.

Di Donato M, Buchbinder R, Iles R, Gray S, Collie A. (2020) Comparison of Compensated Low Back Pain Claims Experience in Australia with Limb Fracture and Non-Specific Limb Condition Claims: A Retrospective Cohort Study. J Occup Rehabil. doi:10.1007/ s10926-020-09906-x.

Leonardo N, Lester S, Graham M, Whittle S, Rowett D, Buchbinder R, Hill CL. (2020) Selection and perception of methotrexate treatment information in people with rheumatoid arthritis. Int J Rheum Dis. 3(6):805-12.

Rozbroj T, Haas R, O’Connor D, Thomas R, McCaffery K, Carter S, Buchbinder R. (2020) Patient and public understanding of overtesting and overdiagnosis: Protocol of a thematic meta-synthesis of qualitative studies. BMJ Open. 10:e037283.

Buchbinder R, Maher C, Underwood M, Hartvigsen J. The Lancet series call to action to reduce low value care for low back pain: An update (invited). Pain. Accepted 2020.

Buchbinder R, Huang H, Ramiro S, Jia Y, Gagnier J, Whittle S. Measures of adult shoulder function (invited). Arthritis Care Res.

Rozbroj T, Lyons A, Lucke J. (2020) Vaccine-Hesitant and Vaccine-Refusing Parents’ Reflections on the Way Parenthood Changed Their Attitudes to Vaccination. J Community Health. 45(1):63-72.

Buchbinder R, Ebeling PR, Akesson K, Bauer DC, Eastell R, Fink GA, Giangregorio L, Guanabens N, Kado D, Kallmes D, Katzman W, Rodriguez A, Wermers R, Wilson HA, Bouxsein ML. (2020) Response to: Some Questions About the Article “The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report”. J Bone Miner Res. 35(1):212-3.

Buchbinder R, Bourne A, Harris I, Latimer J, Taylor W, Whittle S, Richards B, Clavisi O, Green S, Hinman RS, March L, Day R, Ferreira ML, Billot L, Maher C, on behalf of the ANZMUSC Clinical Trials Network. (2020) Early Development of the Australia and New Zealand Musculoskeletal Clinical Trials Network. Intern Med J. 50(1):17-23.

Shaheed CA, Maher CG, Buchbinder R, Ng B, Enke O, Guzowski R, McLachlan AJ, Day RO, Richards B, Latimer J, Lin CW. (2020) Efficacy and harms of orally, intramuscularly or intravenously administered glucocorticoids for sciatica: A systematic review and meta-Analysis. Eur Spine J. 24(3):518-35.

Smith L, Barratt A, Buchbinder R, Harris I, Doust J, Bell K. (2020) Trends in knee magnetic resonance imaging, arthroscopies and joint replacements in older Australians: still too much low-value care? ANZ J Surgery. 90(5):833-9. Roe Y, Buchbinder R, Grotle M, Whittle S, Huang W, Gagnier J, Ramiro S, Verhagen A, Page M, Østensjø S. (2020) What do the OMERACT candidate instruments for shoulder disorders measure? An analysis using the refined ICF linking rules. J Rheumatol. doi: doi. org/10.3899/jrheum.190832.

Mathieson S, Wertheimer G, Maher CG, Lin CWW, McLachlan A, Buchbinder R, Pearson SA, Underwood M. (2020) What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta-regression of observational studies. J Intern Med. 287(5):458-474.

Surace SJ, Deitch J, Johnston RV, Buchbinder R. (2020) Shock wave therapy for rotator cuff disease with or without calcification. Cochrane Database Syst Rev. 3:CD008962.

Beard DJ, Campbell M, Blazeby JM, Carr AJ, Weijer C, Cuthberson B, Buchbinder R, Pinkney T, Bishop F, Pugh J, Cousins S, Harris I, Lohmander S, Blencowe N, Gillies K, Probst P, Brennan C, Farrah-Hockley D, Cook A, Savalescu J, Huxtable R, Rangan A, Tracey I, Brocklehurst P, Lee N, Nicholl J, Reeves B, Hamdy F, Rowley S, Cook J. (2020) Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines). The Lancet. 395(10226):828-38.

Busija L, Ackerman I, Haas R, Wallis J, Nolte S, Bentley S, Miura D, Hawkins M, Buchbinder R. Adult measures of general health and health-related quality of life (invited). Arthritis Care Res.

Di Donato M, Iles R, Lane T, Buchbinder R, Collie A. The impact of income support systems on healthcare quality and functional capacity in workers with low back pain: a realist review. Pain.

Malliaris P, Johnston RV, Seneque G, Littlewood C, Bennell K, Haines T, Buchbinder R. The efficacy of higher versus lower dose exercise in rotator cuff tendinopathy: A systematic review of randomised controlled trials. Arch Phys Med Rehab.

SharmaS, Traeger AC, Reed BJ, Hamilton M, O’Connor DA, Hoffmann TC, Bonner C, Buchbinder R, Maher CG. Clinician and patient beliefs about diagnostic imaging for low back pain: a qualitative evidence synthesis. BMJ Open.

Åkesson K, Chang LY, Yang RS, Chan DC, Buchbinder R, Overgaard S, Bengtsson A, Hurley M, Nordin M, Dahlberg L, Woolf A. Advances in delivery of health care for musculoskeletal conditions (invited). Best Practice Res Clin Rheumatol.

Grants held

NHMRC Senior Principal Research Fellowship. (20152019) $911,915. Buchbinder R.

NHMRC Translating Research into Practice Fellowship. (20192020) $181,066. O’Connor DA.

NHMRC Centre of Research Excellence in Translation of Research into Improved OUtcomes in Musculoskeletal Pain & Health (CRE TRIUMPH). (2015-2019) $2,500,000. Bennell K, Hunter D, Hodges P, Buchbinder R, Pirotta M, Hinman R, Harris A, Foster N, Michie S, Vicenzino B

NHMRC Project Grant. ‘Hype or Hope? platelet-Rich plasma as a symptom- and disEaSemodifying Treatment fOR knee ostEoarthritis - the RESTORE trial’. (2016-2019) $1,400,359. Bennell K, Buchbinder R, Wang Y, Forbes A.

Cabrini Foundation Clinical Research Grant. ‘The Back Pain Quest: Understanding beliefs about low back pain’. (20182019) $30,000. Buchbinder R, Hawkins M, Osborne R.

RACGP Foundation – HCF Grant. ‘OCEAn - NETs (Occasions of Care Explained and Analysed - nominated extra topics).’ (2018-2019) $60,000. Harrison C, Poon S, Gorji N, Gordon J, Bonner C, Bayram C, Maher C, Buchbinder R.

NHMRC Project Grant. ‘CROSSFIRE: Combined Randomised and Observational Study of Surgery for Fractures in the Distal Radius in the Elderly’. (2016-2019) $511,076. Harris I, Buchbinder R, Ivers R, Naylor J, Baloh Z, Smith P.

NHMRC Program Grant. ‘Musculoskeletal pain and disability: improving outcomes through conservative interventions’. (2016-2020), $8,268,140. Hodges P, Bennell K, et al. Buchbinder R (AI).

NHMRC Partnership Grant. ‘Patient-centred eHealth approach to improving outcomes for gout sufferers’. (2016-2020) $660,656. Day R, et al. Buchbinder R (AI).

NHMRC Program Grant. ‘Using healthcare wisely: reducing inappropriate use of tests and treatments’. (20172021) $9,578,895. Glasziou P, Buchbinder R, Maher C, McCaffery K.

NHMRC Partnership Centre in Health System Sustainability. (2017-2022) $10,700,000. (NHMRC $5,250,000; Partners: Bupa Health Foundation, NSW Health, Telstra and the University of Notre Dame Australia). Braithwaite J, Ward RL, Anderson T, Teede H, Wells L, Gray LC, Yeend T, Coiera E, Westbrook J, Glasziou P, Scott A, Karnon JD, Buchbinder R.

NHMRC Project Grant. ‘SUcceSS: Surgery for Spinal Stenosis – a randomised placebo-controlled trial’. (2017-2021) $2,300,000. Ferreira M, Harris I, Davis G, Latimer J, Beard D, Li Q, Mobbs R, Buchbinder R (AI).

NHMRC The Cochrane Collaboration Round 7 Funding Program. ‘Cochrane Musculoskeletal Review Group, Australian Editorial Base’. (20172020) $368,086. Buchbinder R, O’Connor D, Winzenberg T, Johnston R.

NHMRC Centre of Research Excellence. ‘ANZMUSC – Australia and New Zealand Musculoskeletal Clinical Trials Network’. (2018-2022) $2,497,653. Buchbinder R (CI), Maher C, March L, Day R, Hinman R, Harris I, Ferreira M, Glasziou P, Green S, Billot L.

NHMRC Medical Research Future Fund Research Grant. ‘CRISTAL: Cluster Randomised Trial of Aspirin versus Low molecular

weight heparin for venous thromboembolism prophylaxis in joint replacement surgery, a registry-nested study’. (20182022) $910,700. Harris I, Graves S, Buchbinder R, Naylor J, Pratt N, de Steiger R, Chong B, Ackerman I, Harris A.

Academy of Finland. ‘Finnish Imaging of Degenerative Shoulder Study (FIMAGE): A study on the prevalence of degenerative imaging changes of the shoulder and their relevance to clinical symptoms in the general population’. (2018-2022) $450,000. Taimela S, et al.

NHMRC Project grant. ‘Trial of glucocorticoids in acute sciatica’. (2019-2022) $1,142,038. Lin CWC, McLachlan A, Latimer J, Abdel Shaheed C, Li Q. Buchbinder R (CI on trial but AI on grant application as hold a program grant).

Arthritis Queensland, Arthritis South Australia and the Allan and Beryl Stephens Grant. ‘Patterns of care for low back, knee and shoulder conditions by general practitioners in Victoria, Australia’. (2019 – 2020) $31,000. Haas R, Buchbinder R, O’Connor D, Mazza D.

Australian Government Department of Health. ‘Value in Prescribing Program: Biological Disease Modifying AntiRheumatic Drugs (bDMARDs): Value-based prescribing of bDMARDs: a coordinated national program’. (20192022) $8,411,413. Partnership between: NPS MedicineWise (Dartnell J, London J, Heaney A, Hosking K, Yoo J, Elliott J, Granger R, Blogg S, Antonio G), ARA (Hill C, Barrett C, Morabani M, Kubler P, Day R, Clancy M, Buchbinder R [also representing ANZMUSC and Cochrane Musculoskeletal]), ANZMUSC (Whittle S, O’Connor D), Cochrane Musculoskeletal (Johnston R), Arthritis Australia (Mills A, Marine F), Quality Use of Medicines and Pharmacy Research Centre (Rowett D, Roughead L, Ward M, Wiese M), Pharmaceutical Society of Australia (Jackson S, Freeman C, McMaugh J, Ridd J), Society of Hospital Pharmacists of Australia (Michaels K, Jerry Yik J, Hayward K), Council of Australian Therapeutic Advisory Groups (EthertonBeer C, Donnelly J, Bennett S).

Therapeutic Guidelines LTD (TGL)/RACGP Foundation Research Grant (TGL -03). ‘Use of Osteoarthritis Guidelines in General Practice: An Analysis of Work-as-Done Using the Functional Resonance Analysis Method’. (2019-2021) $19,968. Stocks N, Whittle S, ClayWilliams, Buchbinder R.

NHMRC Partnership Project Grant. ‘Improving communication about heart disease risk assessment using translational research strategies in general practice: A project to implement evidence-based guidelines and shared decision-making tools for CVD prevention’. (20192020) $449,368. Bonner C, Trevena L, Doust J, McGeechan K, Greaves K, O’Connor DA, Morgan M, de Wet C.

NHMRC The Cochrane Collaboration Round 8 Funding Program. ‘Cochrane Musculoskeletal Review Group, Australian Editorial base’. (2020-2023) $384,204. Buchbinder R, Johnson R, O’Connor D, Winzenberg T, Maher C, Whittle S.

Cabrini Foundation Clinical Research Grant. ‘Using SUpported Motivational InTervention (SUMIT) to improve physical activity in people with knee osteoarthritis’. (2020-2022) $29,999. Bell E, Wallis J, Barton C, O’Halloran P, Crossley K, Lee A, Jennings S, Gibbs A.

NHMRC Medical Research Future Fund project grant. ‘Reducing inappropriate knee joint replacement surgery and hospital burden’. (2020-2022) $1,337,750. Barton C, Dowsey M, Choong P, Ademi Z, Smith Curtin A, Crossley KM, Wallis JA, Ackerman I, Bunzli S, Kemp JL.

National COVID-19 Clinical Evidence Taskforce. (20202025) Equity Trustees – Walter Cottman Endowment Fund: $100,000 (25/3/20 to 31/12/20); Ian Potter Foundation: $2,500,000 (1/4/2020 to 31/12/2025); MRFF: $1,500,000 (1/4/2020 to 31/3/2022) Elliott J, Green S, Zoungas S, Buchbinder R, Craig J, McGowan S, Tendal B, Tate R, Turner T, McDonald S, Murano M.

Australian Government Department of Health. Public Health and Chronic Disease Program Arthritis - Health Professional Education and Training. (2020-23) $2,018,464. Partnership between: Arthritis Australia, University of Sydney, University of Melbourne, Arthritis and Osteoporosis Australia in partnership with Curtin University, Monash University on behalf of ANZMUSC and Cochrane Musculoskeletal, Australian Rheumatology Association (Buchbinder R, Whittle S).

NHMRC Low Back Pain Centre for Research Excellence (CRE). (2020-2024) $2,499,189. Maher C, Buchbinder R, Hancock M, O’Sullivan P, McAuley J, Blyth F, Jorm L, Collie A, McCaffery K, Hayes A, O’Connor DA (AI).

Arthritis Australia Grant-inAid. ‘The development of a patient decision aid to reduce subacromial decompression’. (2020) $15,000. Zadro J, Maher C, Buchbinder R, Harris I.

NHMRC Ideas Project. ‘TOPCHILD: Transforming Obesity Prevention for CHILDren – Looking into the black box of interventions’. (2020-2023) $411,926. Seidler L. O’Connor DA (AI).

Cabrini Foundation Clinical Research Grant. ‘Evaluating a patient decision aid for people with degenerative knee disease considering arthroscopic surgery: a randomised controlled trial. O’Connor D, Buchbinder R. (2020-2021) $29,745. O’Connor DA, Buchbinder R, Hoffmann T, McCaffery K, Maher C, Harris I, Glasziou P, Billot L, Haas R (AIs: Clavisi O, Gorelik A).

NHMRC Investigator Grant: Leadership 3. (2021-2025) $2,914,215. Buchbinder R.

Cabrini Monash University Department of Surgery, The Fröhlich West Chair of Surgery

Publications, books, book chapters, reports

Bell SW, Heriot AG, Warrier SK, Farmer C, Stevenson A, Bissett I, Kong J, Solomon M. (2019) Surgical techniques in the Management of Rectal Cancer: A Modified-Delphi Method by Colorectal Surgeons in Australia and New Zealand. Techniques in Coloproctology 23:743-749.

Bell S, Venchiarutti R, Warrier S, Stevenson A, Solomon M. (2019) A Perspective on Surgical Randomised Controlled Trials. ANZ Journal of Surgery 89 (9) 998-999.

Bell S, Malouf P, Johnson N, Wale R, Peng Q, Nottle P, Warrier S. (2019) Pelvic fat volume reduction with preoperative VLED: Implications for rectal cancer surgery in the obese. Techniques in Coloproctology 23:887-892.

Engel RM, Chen WH, Nickless D, Hlavca S, Richards E, Kerr G, Oliva K, McMurrick PJ, Jarde T, Abud HE. (2019) Patient-derived colorectal cancer organoids upregulate revival stem cell marker genes following chemotherapeutic treatment. Journal of Clinical Medicine 9, 128; doi:10.3390/jcm9010128

Yap R, Nassif G, Hwang G, Mendez A, Erkan A, Kelly J, Debeche-Adams T, Albert M, Monson J. (2020) Achieving opioid-free major colorectal surgery; is it possible? Digestive Surgery 30:1-7

Rudloff I, Jarde T, Bachmann M, Kerr G, Engel R, Oliva K, Wilkins S, McMurrick P, Abud H, Muhl H, Nold M. (2020) Molecular signature of interlukin-22 in colon carcinoma cells and organoid models. Translational Research 2020; 216:1-22.

Ashkar C, Britto M, Carne P, Cheung W, Mirbagheri N. (2020) Perianal sepsis in neutropaenic patients with

haematological malignancies: the role of magnetic resonance imaging and surgery. ANZ Journal of Surgery doi: 10.1111/ ans.15744.

Baqar A, Wilkins S, Staples M, Oliva K, McMurrick P. (2020) The post-operative impact of oversewing stapled anastomoses in colorectal surgery: A retrospective Australian cohort study. International Journal of Surgery Open 24:91-95.

Albert M, Yap R. (2020) Surgical complications and pitfalls in taTME. Digestive Medicine Research 3:8

Mileto SJ, Jarde T, Childress KO, Jensen JL, Rogers AP, Kerr G, Hutton ML, Sheedio MJ, Bloch SC, Shupe JA, Horvay K, Flores T, Engel R, Wilkins S, McMurrick PJ, Lacy DB, Abud HE, Lyras D. (2020) Clostridioides difficile infection damages colonic stem cells via TcdB, impairing epithelial repair and recovery from disease. Proceedings of the National Academy of Sciences of the United States of America (PNAS) 117(4) 8064-8073

Koulis C, Yap R, Engel R, Jarde T,Wilkins S, Solon G, Shapiro JD, Abud H, McMurrick P. (2020) Personalised medicine-current and emerging predictive and prognostic biomarkers in colorectal cancer. Cancers 12(4) e812.

Engel R, Oliva K, Koulis C, Yap R, McMurrick P. (2020) Predictive factors of complete pathological response in patients with locally advanced rectal cancer International Journal of Colorectal Disease Doi.org/10.1007/s00384-02003633-8

Bell SW, Stevenson A. (2020) Training and accreditation in transanal total mesorectal excision (taTME) (Australasia). Annals of Laparoscopic and Endoscopic Surgery 5:11

Scott M, Konstantatos AH, Bui T, Carne P, O’Donohoe R, Dearaugo S, Donovan S. (2020) Acute colonic pseudoobstruction leading to perforation: a case-control study investigating associations to tapentadol. Journal of Pharmacy Practice and Research 50 (3) 226-232 Bell S. (2020) A perspective on Colorectal Surgery Training in Australia and New Zealand. ANZ Journal of Surgery -202000570 In Press

Book Chapters

Debeche-Adams T, Yap R, Nassif G. Operating Theater Setup and Perioperative Considerations; In: Transanal Minimally Invasive Surgery and Transanal Total Mesorectal Excision (taTME); Ed. Attalah, S; Springer International Publishing 2019

Yap R, Monson J. Condyloma acuminata, In: Current Surgery Therapy, Ed. Cameron, J, 13th Edition, Elsevier, Saunders 2019

Yap R. Focus on Theory: Mastery Learning; In: Advances in Health Professions Education; Ed: Nestal, D (In press)

Grants held

Eirene Lucas Foundation 2019 ‘Anti-cancer compound library resource for drug discovery’ (2019-2020) $10,000 Engel R (CI), McMurrick P (CI)

Cabrini Foundation Research Grant 2020 ‘Personalising cancer medicine: the development of a high throughput drug screening platform using patient-derived colorectal cancer organoids’ (2020-2021) $30,000 Engel R (CI), McMurrick P (CI)

Alan, Ada and Eva Selwyn Clinical Research Grant for the research project titled ‘Personalised medicine for colorectal cancer patients: Utilisation of Organoid Technology, Tissue microarrays and Consensus Molecular Subtypes’ (2019-2020), $30,000 Koulis C (CI), Engel R (CI), McMurrick P (CI)

Cabrini Foundation Research Grant for the research project title ‘Developing a new tissueslice assay for modelling colorectal cancer tumours’ (2019-2020), $30,000 Wilkins S (CI), Fletcher A (CI), Knoblich K (CI), McMurrick P (CI)

Cabrini Institute/Cabrini Foundation Grant ‘Using patient-derived organoids to guide the “watch and wait” nonsurgical approach for rectal cancer’ (2018-2019) $30,000 Engel R (CI), McMurrick P (CI), Abud H (CI)

Collie Foundation ‘Patient reported outcome measures’ $40,000 Wilkins S (CI), McMurrick P (CI)

Collie Foundation ‘Human Organoids’ (2017-2019) $300,000 Wilkins S (CI), McMurrick P (CI)

Victorian Cancer Agency ‘Super enhancer templated RNAs as predictive biomarkers of BET inhibitor sensitivity in prostate and colorectal cancer (20162019) $2,000,000 Firestein R (CI), Azad A (CI), Abud H (CI), McMurrick P (CI), Risbridger G (CI), Wilkins S (CI)

Cancer Australia ‘Translating colorectal cancer organoids into patient care’ (20182020) $597,557 Abud H (CI) Worthley D (CI), Burgess A (CI), McMurrick P (CI), Firestein R (CI), Gibbs P (CI), Clevers H (CI), Price T (CI), Padbury R (CI), Hewett P (CI)

NHMRC Project Grant ‘Role of Snail proteins in mediating intestinal stem cell identity’ (2016-2019) $646,698 Abud H (CI), Hime G (CI), Jones L (CI), McMurrick P (CI)

Margaret Walkom Trust (20182019) $30,000 Koulis C (CI), Wilkins S (CI), McMurrick P (CI)

Centre for Allied Health Research and Education (CAHRE)

Publications, books, book chapters, reports

Brusco NK, Tilley L, Walpole B, Kugler H, Li R, Kennedy E. Morris ME. (2019) Feasibility of increasing the dosage of inpatient occupational therapy and physiotherapy rehabilitation via independent tasks and exercises: ‘My Therapy’. Australian Occupational Therapy Journal. 66(6):739-752.

Pierce JE, O’Halloran R, Menahemi-Falkov M, Togher L, Rose M. (2020) Comparing higher and lower weekly treatment intensity for chronic aphasia: A systematic review and metaanalysis. Neuropsychological Rehabilitation, pp. 1-25. doi: 10.1080/09602011.2020.1768127

Frawley HC, Lin K-Y, Granger C, Higgins R, Butler MDenehy L. (2019) An allied health rehabilitation program for patients following surgery for abdomino-pelvic cancer: a feasibility and pilot clinical study. Supportive Care in Cancer. 28(3):1335-1350.

Cox N, Wilson C, Bennett K, Johnston K, Potter A, Lee AL. (2019) Health-related quality of life and psychological wellbeing are poor in children with bronchiectasis and their parents. ERJ Open Research. 5(3):00063-2019. doi: 10.1183/23120541.00063-2019

Wallis JA, Taylor NF, Bunzli S, Shields N. Experience of living with knee osteoarthritis: a systematic review of qualitative studies. BMJ Open 2019; 9: e030060.

Smith R, Osadnik C, Lee AL. (2020) Educational topics and their rationale for inclusion within pulmonary rehabilitation – a systematic review. Patient Education and Counseling. S0738-3991(20)30196-8. doi: 10.1016/j.pec.2020.04.009

Grants held

Cabrini Foundation. Supported Motivational Interviewing (SUMIT) to improve physical activity for people with knee osteoarthritis, $29,999.65 M Bell (PI), J Wallis, C Barton, P O’Halloran, K Crossley, N Taylor, A Lee, S Jennings, A Gibbs.

ERS/ELF Travel grant award for the best abstract in patientcentred research 2020, €1,500, Lee A (CI)

Cabrini Foundation. The relationship between cardiorespiratory parameters during physical activity following cardiac surgery, $15,000, A Lee (PI), J Gaudin, S Jennings, M Bergin, O Collicoat, B Armstrong, D El-ansary

AURIC Innovation grant. Development and implementation of an academic exercise physiology program

at Cabrini, $200,000, G Richardson (PI), A Lee, P McMurrick, D Rankin, K Young

Cabrini Foundation. Barriers and enablers for referrals and participation in Cabrini’s new evidence-based osteoarthritis management program: Capturing referrer and patient perspectives $30,000, Wallis J (PI), Sherwood J, Brusco NK, Barton C, Crossley K, Ackerman IN, Young K, Jennings S,

Cabrini Foundation, Is spontaneous swallowing reduced in Parkinson’s compared to healthy controls? $20,000, Pierce J (CI), Vogel A, Cormick M, Lawson N

Cabrini Foundation. The development and implementation of a pictorial hospital food menu, $15,000, Matthews C (CI), Coletti S, Kelaart A, Lawson N, Dowd J

Cabrini Monash University Department of Medical Oncology – The Szalmuk Family Department of Medical Oncology

Publications, books, book chapters, reports

Desai J, Gan H, Barrow C, Jameson M, Atkinson V, Haydon A, Millward M, Begbie S, Brown M, Markman B, Patterson W, Hill A, Horvath L, Nagrial A, Richardson G, Jackson C, Friedlander M, Parente P, Tran B, Wang L, Chen Y, Tang Z, Huang W, Wu J, Zeng D, Luo L, Solomon B.J. (2020) Phase I, Open-Label, Dose-Escalation/DoseExpansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors. J Clin Oncol. 38(19):2140-2150. doi:10.1200/ jco.19.02654

Abida W, Campbell D, Patnaik A, Shapiro JD, Sautois B, Vogelzang NJ, Voog EG, Bryce AH, McDermott R, Ricci F, Rowe J, Zhang J, Piulats JM, Fizazi K, Merseburger AS, Higano CS, Krieger LE, Ryan CJ, Feng FY, Simmons AD, Loehr A, Despain D, Dowson M, Green F, Watkins SP, Golsorkhi T, Chowdhury. (2020) Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the phase II TRITON2 Study. Clin Cancer Res. 26(11):24872496. doi:10.1158/1078-0432. ccr-20-0394

Lau DK, Burge M, Roy A, Chau I, Haller DG, Shapiro JD, Peeters M, Pavlakis N, Karapetis CS, Tebbutt NC, Segelov E, Price TJ. (2020) Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019. Expert Review of Anticancer Therapy. 20(4):251-270. doi:10.1 080/14737140.2020.1744439

Roy AC, Shapiro J, Burge M, Karapetis CS, Pavlakis N, Segelov E, Chau I, Lordick F, Chen LT, Barbour A, Tebbutt N, Price T. (2020) Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. Expert Review of Anticancer Therapy. 20(4):305-324. doi: 10.1080/14737140.2020.1746185

Kumari S, Semira C, Lee M, Lee B, Wong R, Nott L, Shapiro J, Gibbs P. (2020) Resection of colorectal cancer liver metastases in older patients. ANZ J Surg. 90(5):796801. doi: 10.1111/ans.15750.

Mason R, Dearden HC, Nguyen B, Soon JA, Smith JL, Randhawa M, Mant A, Warburton L, Lo S, Meniawy T, Guminski A, Parente P, Ali S, Haydon A, Long GV, Carlino MS, Millward M, Atkinson VG, Menzies AM. (2019) Combined ipilimumab and nivolumab first-line and after BRAF-targeted therapy in advanced melanoma. Pigment Cell & Melanoma Research. 33(2):358-365. doi: 10.1111/ pcmr.12831

Eggermont AMM, Kicinski M, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, Krepler C, Ibrahim N, Marreaud S, van Akkooi A, Robert C, Suciu S.(2020) Association Between ImmuneRelated Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomised to Receive Pembrolizumab or Placebo. JAMA Oncol. 6(4):519. doi: 10.1001/ jamaoncol.2019.5570

Bhave P, Haydon A. (2020) Treatment of High Risk Resected Melanoma in Australia: Current Landscape and Practises. Australas J Dermatol. 61(3):203-209. doi: 10.1111/ajd.13309

Owen CN, Shoushtari AN, Chauhan D, Palmieri DJ, Lee B, Rohaan MW, Mangana J, Atkinson V, Zaman F, Young A, Hoeller C, Hersey P, Dummer R, Khattak MA, Millward M, Patel SP, Haydon A, Johnson DB, Lo S, Blank CU, Sandhu S, Carlino MS, Larkin JMG, Menzies AM, Long GV. (2020) Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy. Ann Oncol. 31(8):1075-1082. doi: 10.1016/j. annonc.2020.04.471

Nguyen J, Clements W, McLean C, Haydon A, Moore M, Yap KS, Mar V, Shackleton M. (2020) Metastatic melanoma presenting as intravenous tumour thrombus. Journal of Medical Imaging and Radiat Oncol. doi: 10.1111/17549485.13019.

Grants held

Medical Research Future Funds: Measuring adherence to best practice guidelines for the management of ovarian cancer in Australia to determine the extent to which variation in care influences clinical and patient-reported outcomes, $2.4 million.

State Government: Victorian COVID-19 Cancer Network Grant $5 million AURIC Innovation grant. Development and implementation of an academic exercise physiology program at Cabrini, $200,000, G Richardson (PI), A Lee, P McMurrick, D Rankin, K Young Freda Castan Grant for Lung Cancer $100,000 annually for at least three years

Freda Castran Grant for Lung Cancer $100,000 annually for at least three years (2020-2022)

Paula Reinders Grant $20,000

Cabrini Foundation Grant Round 'Validation of Cabrini's new chemotherapy app'. (20192020) $25,000, Richardson G, Lang T, Seletto K, Hastings J

Cabrini Foundation Quality Improvement Grant 'Combatting Compassion Fatigue and Burnout of oncology nurses through wellness activities'. (2019-2020) $15,000, Seletto K, Lang T

Telematics Trust. 'Patient self-reporting outcomes of chemotherapy app' (2018-2019) $50,000, Richardson G, Lang T

Peter Meese Memorial Oncology Nursing Research Grant. 'Patient Self reported outcomes of toxicity experienced during chemotherapy (2018-2019) $15,000, Hastings J, Lang T, Richardson G

Beverly Barlow Genetic Cancer Research Grant. 'Modelling Human Breast Cancer Disease using an Experimental in-vitro organoid culture system. (20182019) $100,000, Richardson G

Veronica Choo Neo Png Grant for Pancreatic cancer database $100, 000

Palliative and Supportive Care Research Unit

Publications, books, book chapters, reports

Sulistio M, Wojnar R, Key S, Kwok J, Al-Rubaie Z, Michael N. (2020). The role of methadone in cancer-induced bone pain: a retrospective cohort study. Supp Care Cancer. 2020 10.1007/s00520-020-05606-7.

O’Callaghan C, Seah D, Clayton JM, Welz M, Kissane D, Michael N. Spirituality and religiosity in a palliative medicine population: a mixedmethods study. [published online ahead of print, 2020 Jun 4]. BMJ Support Palliat Care. 2020;bmjspcare-2020-002261. doi:10.1136/bmjspcare- 2020002261

O’Callaghan C, Seah D, Clayton JM, Welz M, Kissane D, Georgousopoulou E, Michael N. Palliative Caregivers’ Spirituality, Views About Spiritual Care, and Associations With Spiritual Well-Being: A Mixed Methods Study. Am J Hosp Palliat Care. 2020; 37: 305-313.

Sulistio M, Wojnar R, Michael N. Propofol for palliative sedation. BMJ Support Palliat Care. 2020;10(1):4-6.

Grants held

Cabrini Foundation Medical Oncology Research Grant. A pilot randomised control trial of a video decision support tool (VDST) for advanced care planning in cancer patient caregiver dyads. Michael N (CI), O’Callaghan C (AI), Kissane D. $45,000 AUD (20192020).

Bethlehem Research Foundation Grant, Cabrini Foundation Clinical Research Grant. A diagnostic interview for psychological adjustment and demoralisation. Bobevski I, Burke A, Michael N (AI), Kissane D. $50,000 AUD(20192020).

Cabrini Foundation Clinical Research Grant. A diagnostic interview for psychological adjustment and demoralisation. Bobevski I, Burke A, Michael N (AI), Kissane D. $30,000 AUD (2019-2020).

Doreen Johnson Oncology Research Grant, Cabrini Foundation Clinical Grant Round ‘Meaning and Purpose (MaP) Therapy in Advanced Cancer Patients: A Multi-site Randomised Controlled Trial’ (2018-2019) $50,000 Kissane D, Michael N.

Cabrini Foundation Clinical Grant Round ‘Using the modified Delphi method to establish expert consensus on optimising the applicability of The Code of Ethical Standards for Catholic Health and Aged Care Services in the clinical setting’ (2018-2019) $30,000 O’Callaghan C, Michael N, Fleming D, Symons X, Lynch S, Garner C, Kissane D.

Szalmuk Family Psycho-Oncology Research Unit

Publications, books, book chapters, reports

Aoun SM, Kissane DW, Cafarella PA, Rumbold B, Hogden A, Jiang L. (2020) Grief, depression and anxiety in bereaved caregivers of people with motor neurone disease: a population-based national study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration https://doi.org/ 10.1080/21678421.2020.1790610

Aoun SM, Cafarella PA, Rumbold B, Thomas G, Hogden A, Jiang L, Gregory S, Kissane DW. (2020). Who cares for the bereaved? A national survey of family caregivers of people with motor neurone disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration http://dx.doi.org /10.1080/21678421.2020.1813780

Bailey C, Doyle Z, Dearin J, Michael N, Kissane DW. (2020). Demoralisation and chronic illness in rural Australia: a cross-sectional survey. Palliative and Supportive Care, 18(3):271-276. https://doi. org/10.1017/S1478951519000841

Belvederi Murri M, Zerbinatia L, Ounallia H, Kissane D, Casonia B , Leonia M, Rossia G, Dall’Olioa R, Carusoa R, Nannia MG, Grassi L. (2020) Assessing demoralisation in medically ill patients: Factor structure of the Italian version of the demoralization scale and development of short versions with the item response theory framework. J Psychosomatic Research. 128: 109889. https://doi.org/10.1016/j. jpsychores.2019.109889

Belvederi Murri M, Caruso R, Ounalli H, Zerbinati L, Berretti E, Costa S, Recla E, Folesani F, Kissane DW, Nanni MG, Grassi L. (2020). The relationship between demoralisation and depressive symptoms among patients from the general hospital: network and exploratory graph analysis. Journal of Affective Disorders 276: 137-146.

Brooker J, Julian J, Millar J, Prince HM, Kenealy M, Herbert K, Graham A, Smith R, Kissane DW, Taylor K, Frydenberg M, Porter I, Fletcher J, Chipperfield K, Haines I, Burney S. (2020) A feasibility and acceptability study of an abbreviated version of the Mindful Self-Compassion program for adult cancer patients. Palliative & Supportive Care. 18(2):130-140. https://doi. org/10.1017/s1478951519000737

Cheng J, Chen J, Zhang Y, Kissane D, Yan J. (2020) Translation and psychometric properties for the Demoralisation Scale in Chinese breast cancer patients. European Journal of Oncology Nursing 42: 134140. https://doi.org/10.1016/j. ejon.2019.09.001

Grassi L, Pasquini M, Kissane D, Zerbinati L, Caruso R, Sabato S, Nanni MG, Ounalli H, Maraone A, Roselli V, Belvederi Murri M, Biancosino B, Biondi M. (2020). Exploring and assessing demoralisation in patients with non-psychotic affective disorders. Journal of Affective Disorders 274: 568575. https://doi.org/10.1016/j. jad.2020.05.043

Kelly, B., Handley, T., Kissane, D., Vamos, M., & Attia, J. (2020) “An indelible mark” the response to participation in euthanasia and physician-assisted suicide among doctors: A review of research findings. Palliative and Supportive Care, 18(1): 82-88. https://doi.org/10.1017/ S1478951519000518

Kissane DW. (2020). Education and assessment of psychoexistential symptoms to prevent suicidality in cancer care. Psycho-Oncology vol 29, no 9; https://doi.org/10.1002/ pon5519

Latella LE, Rogers M, Leventhal H, Parker PA, Horowitz S, Matasar MJ, Bylund CL, Kissane DW, Franco K, Banerjee SC. (2020) Fear of cancer recurrence in lymphoma survivors: a descriptive study. Journal of Psychosocial Oncology, 38(3):251-271. https://doi.org/10 .1080/07347332.2019.1677840

Manne S, Kashy D, Kissane D, Zaider T, Heckman C, Penedo F, Virtue S. (2020) Relationship Intimacy Processes During Treatment for CoupleFocused Interventions for Prostate Cancer Patients and their Spouses Journal of Psychosocial Oncology Research. 1(2):e7. https://doi.org/10.1097/ OR9.0000000000000007

Manne S, Kashy DA, Kissane DW, Zaider T, Heckman CJ, Myers Virtue S, Penedo F. (2020) In-session Intimacy Processes and Treatment Outcomes for Two Couple-Focused Interventions for Prostate Cancer Patients and their Spouses. Journal of Psychosocial Oncology Research. 2(2):e19. https://doi.org/10.1097/ OR9.0000000000000019

Mendz GL, Kissane DW. (2020). Agency, autonomy and euthanasia. Journal of Law, Medicine, Ethics. 48: 555-564.

Pirola WE, Paiva BSR, De Oliveira CZ, Kissane DW, Paiva CE. (2020). Validation of the Brazilian version of the Shame and Stigma Scale (SSS-Br) for patients with head and neck cancer. Palliative and Supportive Care, e 1–7. https://doi.org/10.1017/ S1478951519000488

Grants held

Commonwealth Department of Health grant, in collaboration with the University of Notre Dame Australia, as a multi-sited study. 'Education and Assessment of Psycho-existential wellbeing in palliative care.' $1,062,342 Kissane DW, Lobb E, Michael N

Cabrini Foundation Clinical Research Grant. ‘Development of a spiritual concerns checklist. (2018-2020) $50,000. O’Callahan C, Michael N, Kissane DW

Bethlehem Griffiths Research Foundation. ‘Validation of a clinical interview for demoralization’. (2019-2020) $50,000 Bobevski I, Kissane DW, Michael N.

Cabrini Foundation Clinical Research Grant. ‘Validation of a clinical interview for demoralisation’. (2019-2020) $30,000 Bobevski I, Kissane DW, Michael N.

Cabrini Foundation Clinical Research Grant. ‘A pilot randomised control trial of a video decision support tool (VDST) for advanced care planning in cancer patient caregiver dyads’. (2019-2020) $45,000 Michael N, Kissane DW, Jiwa M, Burke A.

Doreen Johnson Oncology Research Grant, Cabrini Foundation Clinical Grant Round ‘Meaning and Purpose (MaP) Therapy in Advanced Cancer Patients: A Multi-site Randomised Controlled Trial’ (2018-2019) $50,000 Kissane D, Michael N.

Cabrini Foundation Clinical Grant Round ‘Using the modified Delphi method to establish expert consensus on optimising the applicability of The Code of Ethical Standards for Catholic Health and Aged Care Services in the clinical setting’ (2018-2019) $30,000 O’Callaghan C, Michael N, Fleming D, Symons X, Lynch S, Garner C, Kissane D.

Alan, Ada and Eva Selwyn Emergency Department

Publications, books, book chapters, reports

Walker K, Tan SI, Fatovich D, et al. (2020) Research capacity of Australian and New Zealand emergency medicine departments. Int J Emerg Med. 13(1):16. doi:10.1186/s12245-02000275-z

Keijzers G, Macdonald SP, Udy AA, et al. (2020) The Australasian Resuscitation In Sepsis Evaluation: Fluids or vasopressors in emergency department sepsis (ARISE FLUIDS), a multi-centre observational study describing current practice in Australia and New Zealand. Emergency medicine Australasia : EMA. doi:10.1111/1742-6723.13469

Jackman C, Laging R, Laging B, Honan B, Arendts G, Walker K. (2020) Older person with vague symptoms in the emergency department: Where should I begin? Emergency medicine Australasia : EMA. 32(1):141-147. doi:10.1111/1742-6723.13433

Heydari F, Redoute J-M, Yuce M, Joe K, Walker K, Ebrahim M. (2020) Clinical study of a chest-based cuffless blood pressure monitoring system. Medical Devices and Sensors. doi:10.1002/mds3.10091

Heydari F, Ebrahim MP, Redoute J-M, Joe K, Walker K, Rasit Yuce M. (2020) A chestbased continuous cuffless blood pressure method: Estimation and evaluation using multiple body sensors. Original Research. Information Fusion. 54:119-127. doi:10.1016/j. inffus.2019.07.001

Rahman MA, Honan B, Glanville T, Hough P, Walker K. (2019) Using data mining to predict emergency department length of stay greater than 4 hours: Derivation and singlesite validation of a decision tree algorithm. Emergency Medicine Australasia : EMA. doi:10.1111/1742-6723.13421

Pour Ebrahim M, Heydari F, Wu T, et al. (2020) Blood Pressure Estimation Using On-body Continuous Wave Radar and Photoplethysmogram in Various Posture and Exercise Conditions. Sci Rep. 9(1):16346. doi:10.1038/s41598-019-52710-8

Cameron P, Mitra D, Walker K, Jackman C. (2019) Haemoptysis. Textbook Chapter. Textbook of adult emergency medicine 5th edition.

Cameron P, Mitra D, Walker K, Jackman C. (2019) Chronic obstructive pulmonary disease. Textbook Chapter. Textbook of adult emergency medicine 5th edition.

Cameron P, Mitra D, Laging R. (2020) Chest pain. Textbook Chapter. Textbook of adult emergency medicine 5th edition.

Cameron P, Mitra D, Laging R. (2019) Acute coronary syndromes. Textbook Chapter. Textbook of adult emergency medicine 5th edition. Grants held

MRFF Monash Partners, Critical Care, rapid translational research flagship program. “Emergency medicine wait time visibility.” (2019-2021), $250,000 Walker K (CI), Joe K, Ben-Meir M.

MRFF Monash Partners. 'Be your best: an innovative co-designed approach to frailty and care-transitions from hospital to home, in people aged 65 years or more.' (20192021), $198,000 Lowthian J (CI), Boyd L (AI), Rose M (AI), Walker K (AI) et al.

Cabrini Auric grant. 'Developing and testing virtual reality tools to reduce agitation in cognitively impaired older people in emergency departments.' (2019-2021), $147,000 Blecher (CI), Walker K (AI) et al

Cabrini Improvement Research Grant. 'My Health Record in the emergency department: An investigation of adoption, utilisation and utility' (20202021), $15,000. Mullins A (CI), M Ben-Meir M, Rankin D, Skouteris H.

Telematics Trust. 'Development of IT software to support nextday nurse follow up phone calls to patients discharged from the emergency department'. (20182019) $50,000 Ben-Meir M, Joe K, Walker K

Intensive Care Research Unit

Publications, books, book chapters, reports

Brewster DJ, Kerr F and Sarode V. (2020) Preparing the intensive care unit for COVID-19: an Australian experience. MJA Insight. https://insightplus.mja.com

Whyler NC, Teng JC, Brewster DJ, Chin R, Cox I, Druce J, Prince HM, Sheffield DA, Teh E, Sarode V. (2019) Diagnosis of West Nile virus encephalitis in a returned traveller. Med J Aust. 211(11):501. doi: 10.5694/mja2.50416

Das A, Anstey M, Bass F, Blythe D, Buhr H, Campbell L, Davda A, Delaney A, Gattas D, Green C, Ferrier J, Hammond N, Palermo A, Pellicano S, Phillips M, Regli A, Roberts B, Ross-King M, Sarode V, Simpson S, Spiller S, Sullivan K, Tiruvoipati R, Haren FV, Waterson S, Yaw LK, Litton E. (2019) Internet health information use by surrogate decision makers of patients admitted to the intensive care unit: a multicentre survey. Crit Care Resusc. 21(4):305-310. PMID: 31778639.

David J Brewster, Nicholas C Chrimes, Thy BT Do, Kirstin Fraser, Chris J Groombridge, Andy Higgs, Matthew J Humar, Timothy J Leeuwenburg, Steven McGloughlin, Fiona G Newman, Chris P Nickson, Adam Rehak, David Vokes and Jonathan J Gatward.(2020) Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group. Med J Aust. 212(10):472481. doi: 10.5694/mja2.50598

Begley JL, Lavery KE, Nickson CP, Brewster DJ. (2020) The aerosol box for intubation in coronavirus disease 2019 patients: an in-situ simulation crossover study. Anaesthesia. 75(8):1014-1021. doi: 10.1111/ anae.15115

Silver A, Adams M, Brewster DJ. (2020) Intubation and “aerosol generating procedures”: why language matters. MJA Insight. https://insightplus.mja.com

Ihle, J. Burrel, A. Philpot, S. Pilcher, D. Murphy, D. Pellegrino, V. (2020) A Protocol that Mandates Postoxygenator and Arterial Blood Gases to Confirm Brain Death on Venoarterial Extracorporeal Membrane Oxygenation. ASAIO Journal. 66(2):e23-e28. doi: 10.1097/ MAT.0000000000001086

Philpot SJ. (2020) Discussing non-beneficial treatment. Emergency Medicine Australasia. 32(3):499-500. doi:10.1111/1742-6723.13529

Philpot SJ, Bilgrami I, Sullivan L. Communicating medical information over the phone in critical care. Crit Care Resuscitation. Accepted for publication June 2020.

McDonald C, Wackett J, Philpot S, Brady B. (2020) Myocarditis in a 47-year-old man with Myasthenia Gravis and Malignant Thymoma following the Administration of a Tyrosine Kinase/CDK Inhibitor. Cancer Therapy and Oncology International Journal. 16(3). doi: 10.19080/ CTOIJ.2020.16.555937

Murphy, D. Krepska, A. (2019) Acute heart failure. Challenging Concepts in Critical Care, pp. 23-34. doi: 10.1093/ med/9780198814924.003.0002

Brewster DJ and Crock C. The COVID-19 pandemic: an opportunity to embed kindness in our healthcare system MJAinsight. June 29 2020.

Peebles RC, Nicholson IK, Schlieff J, Peat A and Brewster DJ. Nurses’ just-in-time training for clinical deterioration: development, implementation and evaluation. Nurse Education Today. 2020; 84 article 104265. https://doi. org/10.1016/j.nedt.2019.104265

Department of Urology

Publications, books, book chapters, reports

Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, Rutherford N, Martin JM, Frydenberg M, Shakher R, Wong LM, Taubman K, Ting Lee S, Hsiao E, Roach P, Nottage M, Kirkwood I, Hayne D, Link E, Marusic P, Matera A, Herschtal A, Iravani A, Hicks RJ, Williams S, Murphy DG; proPSMA Study Group Collaborators (2020). Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7.

Lawrence MG, Pidsley R, Niranjan B, Papargiris M, Pereira BA, Richards M, Teng L, Norden S, Ryan A, Frydenberg M, Stirzaker C, Taylor RA, Risbridger GP, Clark SJ (2020). Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer. Clin Epigenetics. 12(1):48. doi: 10.1186/s13148-020-00836-2.

Lawrence MG, Porter LH, Clouston D, Murphy DG, Frydenberg M, Taylor RA, Risbridger GP (2020). Knowing what’s growing: Why ductal and intraductal prostate cancer matter. Science Translational Medicine. 12(533): pii: eaaz0152. doi: 10.1126/scitranslmed. aaz0152

Grummet J, Gorin MA, Popoert R, O’Brien T, Lamb AD, Hadaschiks B, Radtke JP, Wagenlehner F, Baco E, Moore CM, Embertons M, George AK, Davis JW, Szabo RJ, Buckley R, Loblaw A, Allaway M, Kastner C, Briers E, Royce PL, Frydenberg M, Murphy DG, Woo HH (2020). Trexit 2020: Why the time to abandon transrectal prostate biopsy starts now. Prostate Cancer and Prostatic Diseases. 23(1):62-65. doi: 10.1038/s41391020-0204-8.

Dunn J, Ralph N, Green A, Frydenberg M, Chambers S (2020). Contemporary consumer perspectives on prostate cancer survivorship: Fifty voices. Psycho-Oncology. 29(3):557-563. doi: 10.1002/ pon.5306

Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O’Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A (2020). Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol. 77(4): 508-547. doi: 10.1016/j.eururo.2020.01.012.

Dunn J, Green A Nicolas R, Newton R, Kneebone A, Frydenberg M, Chambers S, Heneka N (2020). Prostate Cancer Survivorship Essentials Framework: Guidelines for Practitioners. BJU International.

Kneebone A, Frase-Browne C, Duchesne G, Fisher R, Frydenberg M, Herschtal A, Williams SG, Delprado W, Haworth A, Joseph DJ, Martin JM, Matthews JHL, Millar JL, Sidhom M, Spry N, Tang CI, Turner S, Wiltshires KL, Woo H, Davis ID, Lim TS, Pearse M (2020). A phase III multicentre randomised trial comparing adjuvant versus early salvage Radiotherapy following a Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP “RAVES” Trial. The Lancet.

Kalapara A, Frydenberg M (2020). The role of open radical nephrectomy in contemporary management of renal cell carcinoma. Translational Andrology and Urology

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, LinaresEspinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N’Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Der Heijden AGV, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A (2020). EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAUESMO Guidelines Committees. Eur Urol. 77(2):223-250. doi: 10.1016/j.eururo.2019.09.035.

Horwich A, Babjuk M, Bellmunt J, Bruins HM, Reijke TMD, Santis MD, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Kwast TVD, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, Bari BD, WD Blok, Visschere PD, Decaestecker K, Dimitropoulos K, Escrig JLD, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, LinaresEspinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller A-C, Müller CR, N’Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen W, PachecoFigueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg J, Roupret M, Rouviere O, Salembier C,

Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Heijden AGVD, Poppel HV, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Witjes JA (2019). EAU–ESMO consensus statements on the management of advanced and variant bladder cancer – an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. Annals of Oncology. 30(11):1697- 1727. doi: 10.1093/ annonc/mdz296.

Kalapara AA, Verbeek JFM, Nieboer D, Fahey M, Gnanapragasam V, Van Hemelrijck M, Lee LS, Bangma CH, Steyerberg EW, Harkin T, Helleman J, Roobol MJ, Frydenberg M; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium (2020). Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative. Eur Urol Oncol. 3(1):80-91. doi: 10.1016/j. euo.2019.08.014.

Bowden P, See AW, Frydenberg M, Haxhimolla H, Costello AJ, Moon D, Ruljancich P, Grummet J, Crosthwaite A, Pranavan G, Peters J, So K, Gwini SM, McKenzie DP, Nolan S, Smyth LML, Everitt C (2020). Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: interim outcomes of a prospective clinical trial. International Journal of Cancer. 146(1):161168. doi: 10.1002/ijc.32509

Pillay B, Moon D, Meyer D, Crowe H, Mann S, Howard N, Wootten A, Frydenberg M (2020). Exploring the impact of providing men with information about potential prostate cancer treatment options prior to receiving biopsy results. Supportive Care in Cancer. 28(2):507-514. doi: 10.1007/s00520-019-04847-5.

Drost FH, Nieboer D, Morgan TM, Carroll PR, Roobol MJ; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP) Consortium, Trock B, Ehdaie B, Carroll P, Filson C, Kim J, Logothetis C, Morgan T, Klotz L, Pickles T, Hyndman E, Moore CM, Gnanapragasam V, Van Hemelrijck M, Dasgupta P, Bangma C, Roobol M, Villers A, Rannikko A, Perry A, Hugosson J, Rubio-Briones J, Bjartell A, Hefermehl L, Shiong LL, Frydenberg M, Kakehi Y, Chung BH (2019). Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts. Eur Urol. 76(5):693-702. doi: 10.1016/j. eururo.2019.07.041.

Chambers SK, Frydenberg M, Dunn J (2019). Quality of life considerations in the treatment of metastatic hormonesensitive prostate cancer. Lancet Oncology. 20(11):14691471. doi: 10.1016/S14702045(19)30628-X.

Frydenberg M (2019). Avoiding biopsy in men with PIRADS 1,2 on multiparametric MRI of the prostate, ready for prime time? BJU International. 124(5):715716. doi: 10.1111/bju.14901.

Frydenberg M. Editorial Comment. (2019). J Urol. 202(6):1247. doi: 10.1097/01. JU.0000585052.78904.db.

Kalapara AA, Nzenza T, Pan HYC, Ballok Z, Ramdave S, O’Sullivan R, Ryan A, Cherk M, Hofman MS, Konety B, Lawrentschuk N, Bolton D, Murphy DG, Grummet JP, Frydenberg M (2019). Detection and localisation of primary prostate cancer using 68GA-PSMA PET/CT compared with mpMRI and radical prostatectomy specimens. BJU Int. doi: 10.1111/bju.14858.[Epub ahead of print] (Accepted for publication: 30th June 2019).

Pereira BA, Lister NL, Hashimoto K, Teng L, FlandesIparraguirre M, Eder A, Sanchez-Herrero A, Niranjan B, Melbourne Urological Research Alliance (MURAL), Frydenberg M, Papargiris MM, Lawrence MG, Taylor RA, Hutmacher DW, Ellem SJ, Risbridger GP, De-Juan-Pardo EM (2019). Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro. Biomaterials. 197:72-85. doi: 10.1016/j. biomaterials.2018.12.030.

Sathianathen NJ, Kalapara A, Frydenberg M, Lawrentschuk N, Weight CJ, Parekh D, Konety BR (2019). Robotic-assisted radical cystectomy vs open radical cystectomy: systematic review and meta-analysis. J Urol. 201(4): 715-720. doi: 10.1016/j.juro.2018.10.006.

van der Kwast TH, Helleman J, Nieboer D, Bruinsma SM, Roobol MJ; Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium, Trock B, Ehdaie B, Carroll P, Filson C, Kim J, Logothetis C, Morgan T, Klotz L, Pickles T, Hyndman E, Moore CM, Gnanapragasam V, Van Hemelrijck M, Dasgupta P, Bangma C, Roobol M, Villers A, Rannikko A, Valdagni R, Perry A, Hugosson J, Rubio-Briones J, Bjartell A, Hefermehl L, Shiong LL, Frydenberg M, Kakehi Y, Chung BH, van der Kwast T, Obbink H, van der Linden W, Hulsen T, de Jonge C, Kattan M, Xinge J, Muir K, Lophatananon A, Fahey M, Steyerberg E, Nieboer D, Zhang L, Guo W, Benfante N, Cowan J, Patil D, Tolosa E, Kim TK, Mamedov A, LaPointe V, Crump T, KimberlyDuffell J, Santaolalla A, Nieboer D, Olivier JT, Rancati T, Ahlgren H, Mascarós J, Löfgren A, Lehmann K, Lin CH, Hirama H, Lee KS, Jenster G, Auvinen A, Bjartell A, Haider M, van Bochove K, Carter B, Gledhill S, Buzza M, Bangma C, Roobol M, Bruinsma S, Helleman J (2019). Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies. Eur Urol Oncol. 2019 May;2(3):333-336. doi: 10.1016/j. euo.2018.08.017

Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, van der Linden W, Nieboer D, Bangma CH, Frydenberg M, Rannikko A, Lee LS, Gnanapragasam VJ, Kattan MW; Members of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 consortium; Members of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 consortium (2019). Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium. Eur Urol 75(3):523-531. doi: 10.1016/j.eururo.2018.10.025.

Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A. (2020). Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol. 77(4): 508-547. doi: 10.1016/j. eururo.2020.01.012.

Bolton D, Frydenberg M (2019). From indecision to precision: advances in imaging in metastatic prostate cancer. World J Urol. 37(7):1237. doi: 10.1007/s00345-019-02820-9.

Harkin T, Elhage O, Chandra A, Khan N, Kiberu Y, Frydenberg M, Dasgupta P (2019). High dectal proportion predicts biochemical recurrence in prostatic ductal adenocarcinoma. BJU International doi: 10.1111/ bju.14831. [Epub ahead of print]

Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvarth LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA,

Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu S, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Sweeney CJ, for the ENZAMET trial investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) (2019). Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer. New England Journal of Medicine. 381(2):121-131. doi: 10.1056/ NEJMoa1903835

Porter LH*, Lawrence MG*, Wang J, Clark AK, Bakshia A, Obinata D, Goode D, Papargiris M, MURAL, Clouston D, Ryan A, Norden S, Grummet J, Kourambas J, Pook D, Sandhu S, Frydenberg M, Murphy D, Taylor RA*, Risbridger GP * (2019). Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer. The Prostate. 79(11):1326-1337. doi: 10.1002/ pros.23839

Frydenberg M (2019). Re: 68Ga-Labeled Prostatespecific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. 76(3): 405. doi: 10.1016/j. eururo.2019.03.039.

McLennan V, Ludvik D, Chambers S, Frydenberg M (2019). Work after prostate cancer: a systematic review. J Cancer Surviv. 13(2): 282-291. doi: 10.1007/s11764-019-007504 - Review

Watt MJ, Clark AK, Selth LA, Haynes VR, Lister N, Rebello R, Porter LH, Niranjan B, Whitby ST, Lo J, Huang C, Schittenhelm RB, Anderson KE, Furic L, Wijayaratne PR, Matzaris M, Montgomery MK, Papargiris M, Norden S, Febbraio M, Risbridger GP, Frydenberg M, Nomura DK, Taylor RA (2019). Suppressing Fatty Acid Uptake has therapeutic effects in preclinical models of prostate cancer. Science Translational Medicine. 11(478). pii: eaau5758. doi: 10.1126/scitranslmed. aau5758.

Grants held

NHMRC. 'Targeting lethal prostate cancer in its infancy'. Risbridger G, Clouston D, Frydenberg M, Murphy D. $764,363.50 (2020-2022)

NHMRC 'Developmental events affecting male fertility and reproductive pathologies' Loveland K, Rajpert-De Meyts E, Schuppe H-C, Meinhardt A, Almstrup K, Jorgensen A, Guo J. (AIs) Frydenberg M, Hedger M, Hobbs R, Tran B. $1,430,000 (2020-2023)

Inherited pathogenic mutations in prostate cancer (Monash) PCFA $490K

Impact of PET PSMA in the management of prostate cancer (Monash Health, VCCC) PCFA $1.3M

Prostate Cancer Foundation of Australia and It's A Bloke Thing Foundation through Prostate Cancer Foundation of Australia's Research Program. 'Inherited pathogenic mutations in prostate cancer: the next generation.' Taylor RA, Thorne H, Frydenberg M, Risbridger GP, Batra J, Schoch W. $490,670 (2019-2022)

Movember Foundation. Prostate Cancer Outcomes Registry – Australia and New Zealand (PCOR-ANZ) Quality Improvement Research Fund. "Realtime App for PCOR-ANZ results: proof of concept and value to Urologists" Brough S, Frydenberg M, Bax K, Clarke J, Frizelle F, Weston M, Evans S, Runting A, Nugara M. $100,000 (2019-2022)

Movember Foundation. Prostate Cancer Outcomes Registry – Australia and New Zealand (PCOR-ANZ) Quality Improvement Research Fund. 'Predicting urinary incontinence and ED after prostate cancer surgery'. Moretti K, O'Callaghan M, Vincent A, Beckmann K, Smith D, Mark S, Frydenberg M, Evans S, Clarke J, Walsh S, Kopsaftis T, Evans M, Merry D. $90,250 (2019-2021)

Movember Foundation. Prostate Cancer Outcomes Registry – Australia and New Zealand (PCOR-ANZ) Quality Improvement Research Fund. 'Clinical-level quality of care reports – dealing with the complex issue of outliers' Evans S, Heathcote P, Fisher J, Kirkman M, Frydenberg M, Mark S, Currow D. $66,259 (2019-2020)

Cancer Council Victoria. 'Targeting lipid metabolism in prostate cancer' Watts MJ, Taylor RA, Nomura D. (AI) Risbridger G, Frydenberg M, Ryan. $300,000 (2019-2021)

NHMRC 'BCG+MM Trial: Adding mitomycin to BCG as adjuvant intravesical therapy for high-risk, non-muscleinvasive bladder cancer: a 2-stage, randomised phase 3 trial' CIs: Hayne D, Stockler M, Frydenberg M, Martin A, Sengupta S, Patel M, Grummet J, Krieger L, McCombie S. $1,587,163.80 (2019-2023)

NHMRC.'Can Exercise Delay Transition to Active Therapy in Men with Low Grade Prostate Cancer? A Multi-Centre Randomised Controlled Trial' CIs: Galvão D, Frydenberg M, Chambers S, Newton R, Hayne D, Taaffe D, Spry N, Hart N. $596,083.90 (2018-2022)

NHMRC. 'Centre for Research Excellence in Prostate Cancer Survivorship (CRE-PCS)' Frydenberg M (AI) $2,498,842 (2016-2020)

Prostate Cancer Foundation of Australia – Movember Clinical Trial Award. 'A prospective multicentre study of the impact of Ga-68 PSMA-PET/CT imaging in the management of prostate cancer (proPSMA study)' CIs: Hofman M (PI), Williams S, Lawrentschuk N, Francis R, Martin J, Roach P, Frydenberg M, Thomas P. $1,272,142 (20162020)

Clinical Education Department

Publications, books, book chapters, reports

Peebles RC, Nicholson IK, Schlieff J, Peat A, Brewster DJ. (2020) Nurses’ just-intime training for clinical deterioration: Development, implementation and evaluation. Nurse Education Today, 84: 104265.

Department of Medical Student Education

Publications, books, book chapters, reports

Brewster DJ and Crock C. (2020) The COVID-19 pandemic: an opportunity to embed kindness in our healthcare system. MJA Insight. https://insightplus.mja.com

Key partners of the Cabrini Institute

Cancer Trials Australia (CTA)

Digital Health Cooperative Research Centre (DHCRC)

Monash Partners Academic Health Science Centre (known as Monash Partners)

Australian Catholic University (ACU)

ACU College

La Trobe University

Monash University

Swinburne University

The University of Melbourne

The University of Notre Dame